The nutraceutical potential of omega-3 alpha-linolenic acid in reducing the consequences of stroke

Biochimie

Volumn 120, Issue , 2016, Pages 49-55

  Blondeau, Nicolas ^a  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Brain preconditioning; Functional food; Ischemia; Neurogenesis; Neuroprotection; Synaptogenesis

Indexed keywords

LINOLENIC ACID; NUTRACEUTICAL; OMEGA 3 FATTY ACID; NEUROPROTECTIVE AGENT;

BRAIN DAMAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DIET SUPPLEMENTATION; HUMAN; MORTALITY; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; NUTRITION; REVIEW; VASODILATATION; ANIMAL; CLINICAL TRIAL (TOPIC); METABOLISM; STROKE;

ALPHA-LINOLENIC ACID; ANIMALS; BRAIN ISCHEMIA; CLINICAL TRIALS AS TOPIC; HUMANS; NEUROPROTECTIVE AGENTS; STROKE;

EID: 84951573075     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2015.06.005     Document Type: Review

References (61)

1. A.S. Go, D. Mozaffarian, V.L. Roger, E.J. Benjamin, J.D. Berry, M.J. Blaha, S. Dai, E.S. Ford, C.S. Fox, S. Franco, H.J. Fullerton, C. Gillespie, S.M. Hailpern, J.A. Heit, V.J. Howard, M.D. Huffman, S.E. Judd, B.M. Kissela, S.J. Kittner, D.T. Lackland, J.H. Lichtman, L.D. Lisabeth, R.H. Mackey, D.J. Magid, G.M. Marcus, A. Marelli, D.B. Matchar, D.K. McGuire, E.R. Mohler III, C.S. Moy, M.E. Mussolino, R.W. Neumar, G. Nichol, D.K. Pandey, N.P. Paynter, M.J. Reeves, P.D. Sorlie, J. Stein, A. Towfighi, T.N. Turan, S.S. Virani, N.D. Wong, D. Woo, and M.B. Turner Heart disease and stroke statistics-2014 update: a report from the American Heart Association Circulation 129 2014 e28 e292
2. A. Gustavsson, M. Svensson, F. Jacobi, C. Allgulander, J. Alonso, E. Beghi, R. Dodel, M. Ekman, C. Faravelli, L. Fratiglioni, B. Gannon, D.H. Jones, P. Jennum, A. Jordanova, L. Jonsson, K. Karampampa, M. Knapp, G. Kobelt, T. Kurth, R. Lieb, M. Linde, C. Ljungcrantz, A. Maercker, B. Melin, M. Moscarelli, A. Musayev, F. Norwood, M. Preisig, M. Pugliatti, J. Rehm, L. Salvador-Carulla, B. Schlehofer, R. Simon, H.C. Steinhausen, L.J. Stovner, J.M. Vallat, P. Van den Bergh, J. van Os, P. Vos, W. Xu, H.U. Wittchen, B. Jonsson, and J. Olesen Cost of disorders of the brain in Europe 2010 Eur. Neuropsychopharmacol 21 2011 718 779
3. D. Lloyd-Jones, R.J. Adams, T.M. Brown, M. Carnethon, S. Dai, G. De Simone, T.B. Ferguson, E. Ford, K. Furie, C. Gillespie, A. Go, K. Greenlund, N. Haase, S. Hailpern, P.M. Ho, V. Howard, B. Kissela, S. Kittner, D. Lackland, L. Lisabeth, A. Marelli, M.M. McDermott, J. Meigs, D. Mozaffarian, M. Mussolino, G. Nichol, V.L. Roger, W. Rosamond, R. Sacco, P. Sorlie, T. Thom, S. Wasserthiel-Smoller, N.D. Wong, and J. Wylie-Rosett Heart disease and stroke statistics-2010 update: a report from the American Heart Association Circulation 121 2010 e46 e215
4. C. Iadecola, and J. Anrather Stroke research at a crossroad: asking the brain for directions Nat. Neurosci 14 2011 1363 1368
5. M. Fisher, and B. Bastan Identifying and utilizing the ischemic penumbra Neurology 79 2012 S79 S85
6. V.E. O'Collins, M.R. Macleod, G.A. Donnan, L.L. Horky, B.H. van der Worp, and D.W. Howells 1,026 experimental treatments in acute stroke Ann. Neurol 59 2006 467 477
7. M. Fisher Recommendations for advancing development of acute stroke therapies: stroke therapy academic industry roundtable 3 Stroke 34 2003 1539 1546
8. J.S. Tauskela, and N. Blondeau Prescription for stroke: should preconditioning be investigated as a drug? B.J. Schaller, Ischemic Tolerance of the Brain 2009 Research Signpost Kerala, India 85 135
9. E.H. Lo Experimental models, neurovascular mechanisms and translational issues in stroke research Br. J. Pharmacol 153 Suppl. 1 2008 S396 S405
10. J. Minnerup, and W.R. Schabitz Multifunctional actions of approved and candidate stroke drugs Neurotherapeutics 6 2009 43 52
11. K. Kitagawa, M. Matsumoto, M. Tagaya, R. Hata, H. Ueda, M. Niinobe, N. Handa, R. Fukunaga, K. Kimura, K. Mikoshiba, and et al. 'Ischemic tolerance' phenomenon found in the brain Brain Res 528 1990 21 24
12. J.M. Gidday Cerebral preconditioning and ischaemic tolerance Nat. Rev. Neurosci 7 2006 437 448
13. H. Plamondon, N. Blondeau, C. Heurteaux, and M. Lazdunski Mutually protective actions of kainic acid epileptic preconditioning and sublethal global ischemia on hippocampal neuronal death: involvement of adenosine A1 receptors and K(ATP) channels J. Cereb. Blood Flow. Metab 19 1999 1296 1308
14. U. Dirnagl, R.P. Simon, and J.M. Hallenbeck Ischemic tolerance and endogenous neuroprotection Trends Neurosci 26 2003 248 254
15. N. Blondeau, H. Plamondon, C. Richelme, C. Heurteaux, and M. Lazdunski K(ATP) channel openers, adenosine agonists and epileptic preconditioning are stress signals inducing hippocampal neuroprotection Neuroscience 100 2000 465 474
16. N. Blondeau, I. Lauritzen, C. Widmann, M. Lazdunski, and C. Heurteaux A potent protective role of lysophospholipids against global cerebral ischemia and glutamate excitotoxicity in neuronal cultures J. Cereb. Blood Flow. Metab 22 2002 821 834
17. N. Blondeau, C. Widmann, M. Lazdunski, and C. Heurteaux Polyunsaturated fatty acids induce ischemic and epileptic tolerance Neuroscience 109 2002 231 241
18. N. Blondeau, and J.S. Tauskela A new future in brain preconditioning based on nutraceuticals: a focus on a-linolenic omega-3 fatty acid for stroke protection J.M. Gidday, M.A. Perez-Pinzon, J.H. Zhang, Innate Tolerance in the CNS 2013 Springer New York New York 133 163
19. C. Nguemeni, E. Gouix, M. Bourourou, C. Heurteaux, and N. Blondeau Alpha-linolenic acid: a promising nutraceutical for the prevention of stroke PharmaNutrition 1 2013 1 8
20. E.K. Kalra Nutraceutical-definition and introduction AAPS PharmSci 5 2003 E25
21. K. He, Y. Song, M.L. Daviglus, K. Liu, L. Van Horn, A.R. Dyer, and P. Greenland Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies Circulation 109 2004 2705 2711
22. J.C. Stanley, R.L. Elsom, P.C. Calder, B.A. Griffin, W.S. Harris, S.A. Jebb, J.A. Lovegrove, C.S. Moore, R.A. Riemersma, and T.A. Sanders UK food standards agency workshop report: the effects of the dietary n-6:n-3 fatty acid ratio on cardiovascular health Br. J. Nutr 98 2007 1305 1310
23. G.I.p.l.S.d.S.n.I. miocardico Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial Lancet 354 1999 447 455
24. M. Yokoyama, H. Origasa, M. Matsuzaki, Y. Matsuzawa, Y. Saito, Y. Ishikawa, S. Oikawa, J. Sasaki, H. Hishida, H. Itakura, T. Kita, A. Kitabatake, N. Nakaya, T. Sakata, K. Shimada, and K. Shirato Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis Lancet 369 2007 1090 1098
25. A. Messori, V. Fadda, D. Maratea, and S. Trippoli omega-3 fatty acid supplements for secondary prevention of cardiovascular disease: from "no proof of effectiveness" to "proof of no effectiveness" JAMA Intern. Med 173 2013 1466 1468
26. S.M. Kwak, S.K. Myung, Y.J. Lee, and H.G. Seo Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials Arch. Intern. Med 172 2012 686 694
27. R.M. Krauss, R.H. Eckel, B. Howard, L.J. Appel, S.R. Daniels, R.J. Deckelbaum, J.W. Erdman Jr., P. Kris-Etherton, I.J. Goldberg, T.A. Kotchen, A.H. Lichtenstein, W.E. Mitch, R. Mullis, K. Robinson, J. Wylie-Rosett, S. St Jeor, J. Suttie, D.L. Tribble, and T.L. Bazzarre AHA dietary guidelines: revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association Circulation 102 2000 2284 2299
28. N.J. Stone Fish consumption, fish oil, lipids, and coronary heart disease Circulation 94 1996 2337 2340
29. P.M. Kris-Etherton, W.S. Harris, and L.J. Appel Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease Circulation 106 2002 2747 2757
30. A. Martin The "apports nutritionnels conseilles (ANC)" for the French population Reprod. Nutr. Dev 41 2001 119 128
31. A.T. Michael-Titus Omega-3 fatty acids and neurological injury Prostagl. Leukot. Essent. Fat. Acids 77 2007 295 300
32. M. de Lorgeril, and P. Salen Alpha-linolenic acid and coronary heart disease Nutr. Metab. Cardiovasc. Dis 14 2004 162 169
33. G. Barcelo-Coblijn, and E.J. Murphy Alpha-linolenic acid and its conversion to longer chain n-3 fatty acids: benefits for human health and a role in maintaining tissue n-3 fatty acid levels Prog. Lipid Res 48 2009 355 374
34. N. Hussein, E. Ah-Sing, P. Wilkinson, C. Leach, B.A. Griffin, and D.J. Millward Long-chain conversion of [13C]linoleic acid and alpha-linolenic acid in response to marked changes in their dietary intake in men J. Lipid Res 46 2005 269 280
35. R.J. Pawlosky, J.R. Hibbeln, J.A. Novotny, and N. Salem Jr. Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans J. Lipid Res 42 2001 1257 1265
36. G.C. Burdge, and P.C. Calder Dietary alpha-linolenic acid and health-related outcomes: a metabolic perspective Nutr. Res. Rev 19 2006 26 52
37. C. Wang, W.S. Harris, M. Chung, A.H. Lichtenstein, E.M. Balk, B. Kupelnick, H.S. Jordan, and J. Lau n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review Am. J. Clin. Nutr 84 2006 5 17
38. J. de Goede, W.M. Verschuren, J.M. Boer, D. Kromhout, and J.M. Geleijnse Alpha-linolenic acid intake and 10-year incidence of coronary heart disease and stroke in 20,000 middle-aged men and women in the Netherlands PLoS One 6 2011 e17967
39. J.A. Simon, J. Fong, J.T. Bernert Jr., and W.S. Browner Serum fatty acids and the risk of stroke Stroke 26 1995 778 782
40. G. Zhao, T.D. Etherton, K.R. Martin, P.J. Gillies, S.G. West, and P.M. Kris-Etherton Dietary alpha-linolenic acid inhibits proinflammatory cytokine production by peripheral blood mononuclear cells in hypercholesterolemic subjects Am. J. Clin. Nutr 85 2007 385 391
41. F.M. van der Valk, D.F. van Wijk, and E.S. Stroes Novel anti-inflammatory strategies in atherosclerosis Curr. Opin. Lipidol 23 2012 532 539
42. L. Djousse, S.C. Hunt, D.K. Arnett, M.A. Province, J.H. Eckfeldt, and R.C. Ellison Dietary linolenic acid is inversely associated with plasma triacylglycerol: the National Heart, Lung, and Blood Institute Family Heart Study Am. J. Clin. Nutr 78 2003 1098 1102
43. A.P. Simopoulos Overview of evolutionary aspects of omega 3 fatty acids in the diet World Rev. Nutr. Diet 83 1998 1 11
44. T. Shimokawa, A. Moriuchi, T. Hori, M. Saito, Y. Naito, H. Kabasawa, Y. Nagae, M. Matsubara, and H. Okuyama Effect of dietary alpha-linolenate/linoleate balance on mean survival time, incidence of stroke and blood pressure of spontaneously hypertensive rats Life Sci 43 1988 2067 2075
45. J.M. Bourre, O. Dumont, G. Pascal, and G. Durand Dietary alpha-linolenic acid at 1.3 g/kg maintains maximal docosahexaenoic acid concentration in brain, heart and liver of adult rats J. Nutr 123 1993 1313 1319
46. C. Pudelkewicz, J. Seufert, and R.T. Holman Requirements of the female rat for linoleic and linolenic acids J. Nutr 94 1968 138 146
47. C. Nguemeni, B. Delplanque, C. Rovere, N. Simon-Rousseau, C. Gandin, G. Agnani, J.L. Nahon, C. Heurteaux, and N. Blondeau Dietary supplementation of alpha-linolenic acid in an enriched rapeseed oil diet protects from stroke Pharmacol. Res 61 2010 226 233
48. J.K. Relton, P.J. Strijbos, A.L. Cooper, and N.J. Rothwell Dietary N-3 fatty acids inhibit ischaemic and excitotoxic brain damage in the rat Brain Res. Bull 32 1993 223 226
49. R.A. Voskuyl, M. Vreugdenhil, J.X. Kang, and A. Leaf Anticonvulsant effect of polyunsaturated fatty acids in rats, using the cortical stimulation model Eur. J. Pharmacol 341 1998 145 152
50. I. Lauritzen, N. Blondeau, C. Heurteaux, C. Widmann, G. Romey, and M. Lazdunski Polyunsaturated fatty acids are potent neuroprotectors EMBO J. 19 2000 1784 1793
51. V.R. King, W.L. Huang, S.C. Dyall, O.E. Curran, J.V. Priestley, and A.T. Michael-Titus Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat J. Neurosci 26 2006 4672 4680
52. L. Lang-Lazdunski, N. Blondeau, G. Jarretou, M. Lazdunski, and C. Heurteaux Linolenic acid prevents neuronal cell death and paraplegia after transient spinal cord ischemia in rats J. Vasc. Surg 38 2003 564 575
53. N. Blondeau, O. Petrault, S. Manta, V. Giordanengo, P. Gounon, R. Bordet, M. Lazdunski, and C. Heurteaux Polyunsaturated fatty acids are cerebral vasodilators via the TREK-1 potassium channel Circ. Res 101 2007 176 184
54. N. Blondeau, C. Widmann, M. Lazdunski, and C. Heurteaux Activation of the nuclear factor-kappaB is a key event in brain tolerance J. Neurosci 21 2001 4668 4677
55. C. Heurteaux, N. Guy, C. Laigle, N. Blondeau, F. Duprat, M. Mazzuca, L. Lang-Lazdunski, C. Widmann, M. Zanzouri, G. Romey, and M. Lazdunski TREK-1, a K+ channel involved in neuroprotection and general anesthesia EMBO J. 23 2004 2684 2695
56. C. Heurteaux, C. Laigle, N. Blondeau, G. Jarretou, and M. Lazdunski Alpha-linolenic acid and riluzole treatment confer cerebral protection and improve survival after focal brain ischemia Neuroscience 137 2006 241 251
57. Y.F. Xiao, S.N. Wright, G.K. Wang, J.P. Morgan, and A. Leaf Fatty acids suppress voltage-gated Na+ currents in HEK293t cells transfected with the alpha-subunit of the human cardiac Na+ channel Proc. Natl. Acad. Sci. U. S. A. 95 1998 2680 2685
58. N. Blondeau, C. Nguemeni, D.N. Debruyne, M. Piens, X. Wu, H. Pan, X. Hu, C. Gandin, R.H. Lipsky, J.C. Plumier, A.M. Marini, and C. Heurteaux Subchronic alpha-linolenic acid treatment enhances brain plasticity and exerts an antidepressant effect: a versatile potential therapy for stroke Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol 34 2009 2548 2559
59. G. Pignataro, A. Scorziello, G. Di Renzo, and L. Annunziato Post-ischemic brain damage: effect of ischemic preconditioning and postconditioning and identification of potential candidates for stroke therapy FEBS J. 276 2009 46 57
60. A.M. Stowe, T. Altay, A.B. Freie, J.M. Gidday, Repetitive hypoxia extends endogenous neurovascular protection for stroke, Ann. Neurol. 69, 975-985.
61. N. Blondeau, R.H. Lipsky, M. Bourourou, M.W. Duncan, P.B. Gorelick, and A.M. Marini Alpha-linolenic acid: an Omega-3 fatty acid with neuroprotective properties: ready for use in the stroke clinic? Biomed. Res. Int 2015 2015 10.1155/2015/519830 519830